Continuous veno - venous hemofiltration in the chemical burn of acute renal failure in the clinical application of.doc

 PAGE \* MERGEFORMAT 4 Continuous veno - venous hemofiltration in the chemical burn of acute renal failure in the clinical application of Author: WU Rong-Ching Chen Mei-Ying Wang Zheng-Ping Zhou Qiao Yang Jianqiu [Keywords:] continuous veno - venous hemofiltration chemical burns clinical application of acute renal failure After severe chemical burns, chemical absorption through the skin and respiratory tract, leading to organ damage, the early acute renal failure (acute renal failure, ARF) are more common, it is sometimes burned, and not too serious, but the combined organ function barriers, increasing the difficulties of treatment are often required continuous renal replacement therapy (continuous renal replacenent thery, CRRT) treatment, CRRT, including continuous arteriovenous hemofiltration, continuous veno - venous hemofiltration (continuous venou-svenous hemofiltration, CVVH), etc. which is commonly used in clinical CVVH. The research and application CVVH after emergency treatment of chemical burns caused by ARF 8 patients received a good effect. Reports are summarized below. 1 Data and methods 1.1 General Information Select from September 2004 to February 2007 period 8 patients were chemical burns, seven cases were male, 1 female, aged 25 to 54 years old, mean age (37.25 ± 9.55) years of age. Chemical burns factors were: 1 cases of concentrated sulfuric acid, aqua regia 1 case, 5 cases of phenol, ammonia vapor in 1 case. Chemical burns of 35% to 99% burn surface area (total body burn area, TBSA), the whole group of patients were complicated with ARF. ARF diagnostic criteria [1]: No shortage of blood volume, urine output amp;lt;17ml / h, continued for more than 6h, diuretics, urine does not increase after impact; or serum creatinineamp;gt; 176.8μ mol / L. CVVH before the blood urea nitrogen of (22.51 ± 10.52) mmol / L, serum creatinine is (364.42 ± 42.37) μ mol / L. 1.2 Treatment of vascular access in 8 patients, 7 patients with femoral vein sing